FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    un Is a General adjectival modifier false Inferred relationship Some
    un Is a nombre false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely morphine sulfate 120 milligram/1 each prolonged-release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely paracetamol 125 milligram/1 each conventional release rectal suppository (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely nicotinic acid 500 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Prednisolone (as prednisolone sodium phosphate) 5 mg rectal suppository Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely felodipine 10 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Fluvastatin (as fluvastatin sodium) 80 mg prolonged-release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely lithium carbonate 200 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely mesalazine 250 milligram/1 each gastro-resistant oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely mirabegron 25 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely etodolac 600 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Metoclopramide hydrochloride 15 mg prolonged-release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely prochlorperazine maleate 5 milligram/1 each conventional release rectal suppository (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Felodipine 5 mg prolonged-release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Sodium valproate 200 mg prolonged-release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely gliclazide 30 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Nifedipine 40 mg prolonged-release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely morphine sulfate 100 milligram/1 each prolonged-release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Nifedipine 20 mg prolonged-release oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely naproxen 500 milligram/1 each gastro-resistant oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Nisoldipine 30 mg prolonged-release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely omeprazole 10 milligram/1 each gastro-resistant oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely fesoterodine fumarate 4 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Oxycodone hydrochloride 5 mg prolonged-release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely flurbiprofen 200 milligram/1 each prolonged-release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Lithium carbonate 450 mg prolonged-release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) Has presentation strength numerator value False un Inferred relationship Some 1
    Product containing precisely valproic acid 500 milligram/1 each gastro-resistant oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Venlafaxine (as venlafaxine hydrochloride) 150 mg prolonged-release oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely verapamil hydrochloride 120 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely trifluoperazine (as trifluoperazine hydrochloride) 2 milligram/1 each prolonged-release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Valproic acid 150 mg gastro-resistant oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely valproic acid 300 milligram/1 each gastro-resistant oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely verapamil hydrochloride 120 milligram/1 each prolonged-release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Trifluoperazine (as trifluoperazine hydrochloride) 10 mg prolonged-release oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Trifluoperazine (as trifluoperazine hydrochloride) 15 mg prolonged-release oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely trospium chloride 60 milligram/1 each prolonged-release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely zinc sulfate monohydrate 125 milligram/1 each conventional release effervescent oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Tramadol hydrochloride 75 mg prolonged-release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely verapamil hydrochloride 240 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Verapamil hydrochloride 180 mg prolonged-release oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely venlafaxine (as venlafaxine hydrochloride) 75 milligram/1 each prolonged-release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely verapamil hydrochloride 240 milligram/1 each prolonged-release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely trandolapril 2 milligram and verapamil hydrochloride 180 milligram/1 each prolonged-release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely trandolapril 2 milligram and verapamil hydrochloride 180 milligram/1 each prolonged-release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely valproic acid (as valproate semisodium) 500 milligram/1 each gastro-resistant oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely valproic acid (as valproate semisodium) 250 milligram/1 each gastro-resistant oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 3
    Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 4
    Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Vortioxetine (as vortioxetine hydrobromide) 5 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely vortioxetine (as vortioxetine hydrobromide) 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely vortioxetine (as vortioxetine hydrobromide) 15 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Vortioxetine (as vortioxetine hydrobromide) 20 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Dolutegravir (as dolutegravir sodium) 10 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Dolutegravir (as dolutegravir sodium) 10 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely dolutegravir (as dolutegravir sodium) 25 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely dolutegravir (as dolutegravir sodium) 25 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely atomoxetine (as atomoxetine hydrochloride) 40 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely amlodipine besilate 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False un Inferred relationship Some
    Bisoprolol fumarate 2.5 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely chlorphenamine 4 milligram/1 each conventional release oral tablet Count of base of active ingredient False un Inferred relationship Some
    Dasatinib 70 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Cefixime 200 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Dehydroepiandrosterone 5 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Avanafil 50 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely ciprofloxacin hydrochloride 750 milligram/1 each conventional release oral tablet Count of base of active ingredient False un Inferred relationship Some
    Carbamazepine 250 mg rectal suppository Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely chlordiazepoxide (as chlordiazepoxide hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Cortisone acetate 25 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Aripiprazole 30 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely aspirin 150 milligram/1 each conventional release rectal suppository (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely bosutinib monohydrate 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False un Inferred relationship Some
    Bezafibrate 200 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely ciclosporin 25 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Dexchlorpheniramine maleate 6 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Dapsone 25 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely cefuroxime axetil 601.44 milligram/1 each conventional release oral tablet Count of base of active ingredient False un Inferred relationship Some
    Avanafil 100 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Buprenorphine (as buprenorphine hydrochloride) 2 mg sublingual tablet Count of base of active ingredient False un Inferred relationship Some
    Cefprozil 250 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Atenolol 25 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely atomoxetine (as atomoxetine hydrochloride) 60 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely cinnarizine 75 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely ciclosporin 100 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Acetohexamide 500 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Carvedilol 12.5 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Avanafil 200 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Amisulpride 400 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely carbamazepine 100 milligram/1 each conventional release chewable tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely delavirdine mesilate 200 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram/1 each conventional release sublingual tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely ceftibuten 400 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely atomoxetine (as atomoxetine hydrochloride) 80 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely budesonide 3 milligram/1 each gastro-resistant oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Colesevelam hydrochloride 625 mg oral tablet Count of base of active ingredient False un Inferred relationship Some

    Start Previous Page 40 of 215 Next End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start